Assetmark Inc. Sells 10,699 Shares of Universal Health Services, Inc. (NYSE:UHS)

Assetmark Inc. reduced its position in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) by 91.8% in the first quarter, according to its most recent filing with the SEC. The fund owned 953 shares of the health services provider's stock after selling 10,699 shares during the quarter. Assetmark Inc.'s holdings in Universal Health Services were worth $179,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of UHS. Invesco Ltd. raised its holdings in Universal Health Services by 25.6% during the 4th quarter. Invesco Ltd. now owns 1,241,340 shares of the health services provider's stock valued at $222,721,000 after buying an additional 253,385 shares during the period. Freestone Grove Partners LP purchased a new stake in Universal Health Services during the 4th quarter valued at $41,155,000. AQR Capital Management LLC raised its holdings in Universal Health Services by 59.4% during the 4th quarter. AQR Capital Management LLC now owns 590,389 shares of the health services provider's stock valued at $105,928,000 after buying an additional 219,942 shares during the period. Bridgewater Associates LP raised its holdings in Universal Health Services by 119.1% during the 4th quarter. Bridgewater Associates LP now owns 322,163 shares of the health services provider's stock valued at $57,802,000 after buying an additional 175,131 shares during the period. Finally, Raymond James Financial Inc. purchased a new stake in Universal Health Services during the 4th quarter valued at $29,301,000. 86.05% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Maria Ruderman Singer sold 1,097 shares of the firm's stock in a transaction dated Wednesday, May 14th. The stock was sold at an average price of $191.48, for a total transaction of $210,053.56. Following the sale, the director owned 7,884 shares of the company's stock, valued at $1,509,628.32. This trade represents a 12.21% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 16.40% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

UHS has been the topic of several recent research reports. Royal Bank Of Canada decreased their price target on Universal Health Services from $211.00 to $201.00 and set a "sector perform" rating on the stock in a report on Wednesday, April 30th. Wall Street Zen upgraded Universal Health Services from a "buy" rating to a "strong-buy" rating in a research note on Saturday. Robert W. Baird reiterated a "neutral" rating and issued a $224.00 target price (down previously from $274.00) on shares of Universal Health Services in a research note on Tuesday, April 15th. Baird R W lowered Universal Health Services from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Finally, Bank of America lowered Universal Health Services from a "neutral" rating to an "underperform" rating and reduced their target price for the stock from $215.00 to $185.00 in a research note on Wednesday, July 16th. One analyst has rated the stock with a sell rating, eight have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Universal Health Services presently has an average rating of "Hold" and a consensus target price of $218.92.

Universal Health Services Stock Performance

Shares of Universal Health Services stock opened at $162.98 on Monday. The firm has a market cap of $10.59 billion, a P/E ratio of 8.58, a P/E/G ratio of 0.67 and a beta of 1.24. The company has a current ratio of 1.29, a quick ratio of 1.19 and a debt-to-equity ratio of 0.64. Universal Health Services, Inc. has a 12 month low of $152.33 and a 12 month high of $243.25. The stock's fifty day moving average price is $176.95 and its 200-day moving average price is $179.82.

Universal Health Services (NYSE:UHS - Get Free Report) last announced its quarterly earnings results on Monday, July 28th. The health services provider reported $5.35 EPS for the quarter, beating the consensus estimate of $4.85 by $0.50. The firm had revenue of $4.28 billion for the quarter, compared to analyst estimates of $4.24 billion. Universal Health Services had a return on equity of 18.22% and a net margin of 7.66%. The business's revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the firm posted $4.31 earnings per share. On average, equities research analysts expect that Universal Health Services, Inc. will post 15.92 earnings per share for the current fiscal year.

Universal Health Services Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 16th. Investors of record on Tuesday, September 2nd will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Tuesday, September 2nd. This represents a $0.80 dividend on an annualized basis and a yield of 0.5%. Universal Health Services's dividend payout ratio (DPR) is presently 4.21%.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.